Upgrade to SI Premium - Free Trial

Deciphera Pharmaceuticals (DCPH) Misses Q4 EPS by 18c

February 8, 2022 4:13 PM

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q4 EPS of ($1.51), $0.18 worse than the analyst estimate of ($1.33). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $23.29 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Categories

Earnings

Next Articles